Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Redenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Related Post

Redenlab at the Digital Health and AI Innovation Summit 2024

  • Posted on 4 September, 2024
    Dr. Adam Vogel, CSO of Redenlab, will be speaking alongside Dr. Tairmae Kangarloo, Associate Director of Digital Strategy at Takeda,...
    Read more

    Redenlab at the 14th International Conference on Frontotemporal Dementias (ICFTD), 19 – 22 September 2024

    • Posted on 3 September, 2024
      Redenlab is proud to announce our participation in the 14th International Conference on Frontotemporal Dementias (ICFTD), to be held in...
      Read more

      Redenlab at the 39th Annual HDSA – May 30 – June 1

      • Posted on 30 May, 2024
        Join Redenlab at the upcoming Huntington’s Disease Society of America (HDSA) National Convention, starting on the 30th of May 2024...
        Read more